Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism

Brain Research

Volumn 1170, Issue SUPPL.: COMPLETE, 2007, Pages 119-128

  Rodríguez Manotas, Miguel ^a   Amorín Díaz, Manuel ^b   Cañizares Hernández, Francisco ^a   Ruíz Espejo, Francisco ^a   Martínez Vidal, Salvadora ^b   González Sarmiento, Rogelio ^c   Martínez Hernández, Pedro ^a   Cabezas Herrera, Juan ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Hospital Comarcal del Noroeste   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Alzheimer's disease; Late onset; Polymorphism; Presenilin

Indexed keywords

APOLIPOPROTEIN E; PRESENILIN 1;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PS 1 GENE; RISK FACTOR; SPAIN;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTRONS; POLYMORPHISM, GENETIC; PRESENILIN-1; RISK; SPAIN;

EID: 34548541805     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.032     Document Type: Article

References (61)

1. Aldudo J., Bullido M.J., Frank A., and Valdivieso F. Presenilin-1 genotype (2/2) is associated with late-onset Alzheimer's disease in Spanish patients. Alzheimer's Res. 3 (1997) 141-144
2. Bagli M., Papassotiropoulos A., Schwab S.G., Jessen F., Rao M.L., Maier W., and Heun R. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population. J. Neurol. Sci. 167 (1999) 34-36
3. Bentahir M., Nyabi O., Verhamme J., Tolia A., Horre K., Wiltfang J., Esselmann H., and De S.B. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J. Neurochem. 96 (2006) 732-742
4. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., and Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo1. Neuron 17 (1996) 1005-1013
5. Brookes A.J., Howell W.M., Woodburn K., Johnstone E.C., and Carothers A. Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease1. Lancet 350 (1997) 336-337
6. Cai X., Stanton J., Fallin D., Hoyne J., Duara R., Gold M., Sevush S., Scibelli P., Crawford F., and Mullan M. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples2. Am. J. Med. Genet. 74 (1997) 202-203
7. Chandak G.R., Sridevi M.U., Vas C.J., Panikker D.M., and Singh L. Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India1. Hum. Biol. 74 (2002) 683-693
8. Combarros O., Alvarez-Arcaya A., Oterino A., Berciano J., Delgado-Rodriguez M., Pena N., Fernandez-Viadero C., Luis Perez-Lopez J., Setien S., and Carvajal A. Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease. J. Neurol. Sci. 171 (1999) 88-91
9. Cui T., Zhou X., Jin W., Zhen F., and Cao X. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Chin. Med. J. (Engl) 113 (2000) 340-344
10. De Jonghe C., Cruts M., Rogaeva E.A., Tysoe C., Singleton A., Vanderstichele H., Meschino W., Dermaut B., Vanderhoeven I., Backhovens H., Vanmechelen E., Morris C.M., Hardy J., Rubinszein D.C., St George-Hyslop P.H., and Van Broeckhoven C. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum. Mol. Genet. 8 (1999) 1529-1540
11. Deng Y., Tarassishin L., Kallhoff V., Peethumnongsin E., Wu L., Li Y.M., and Zheng H. Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology6. J. Neurosci. 26 (2006) 3845-3854
12. Dermaut B., Roks G., Theuns J., Rademakers R., Houwing-Duistermaat J.J., Serneels S., Hofman A., Breteler M.M., Cruts M., Van Broeckhoven C., and van Duijn C.M. Variable expresion of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease. J. Neurol. 248 (2001) 935-939
13. De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 38 (2003) 9-12
14. Elbaz A., and Alperovitch A. Bias in association studies resulting from gene-environment interactions and competing risks. Am. J. Epidemiol. 155 (2002) 265-272
15. Excoffier L., Laval G., and Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evolutionary bioinformatics online 1 (2005) 47-50
16. Ezquerra M., Blesa R., Tolosa E., Lopez P.S., Aguilar M., Pena J., Van B.C., Ballesta F., and Oliva R. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci. Lett. 227 (1997) 201-204
17. Helisalmi S., Mannermaa A., Lehtovirta M., Ryynanen M., Riekkinen Sr. P., and Soininen H. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. Neurosci. Lett. 231 (1997) 56-58
18. Higuchi S., Muramatsu T., Matsushita S., Arai H., and Sasaki H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347 (1996) 1186
19. Hu C.J., Sung S.M., Liu H.C., and Chang J.G. Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese. J. Neurol. Sci. 157 (1998) 158-161
20. Hutton M., and Hardy J. The presenilins and Alzheimer's disease. Hum. Mol. Genet. 6 (1997) 1639-1646
21. Isoe K., Urakami K., Ji Y., Adachi Y., and Nakashima K. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol. Scand. 94 (1996) 326-328
22. Jia L., Zhou C., Lv H., Wang W., Ye J., Zhang X., Zhou W., Xu J., Wang L., and Jia J. Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population. Brain Res. 1116 (2006) 201-205
23. Juhasz A., Palotas A., Janka Z., Rimanoczy A., Palotas M., Bodi N., Boda K., Zana M., Vincze G., and Kalman J. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population. Neurochem. Res. 30 (2005) 591-596
24. Kehoe P., Williams J., Lovestone S., Wilcock G., and Owen M.J. Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group. Lancet 347 (1996) 1185
25. Kim K.W., Jhoo J.H., Lee K.U., Lee D.Y., Lee J.H., Youn J.Y., Lee B.J., and Woo J.I. No association between presenilin 1 (PS1) intronic polymorphism and sporadic Alzheimer's disease in Koreans. J. Neural Transm. 107 (2000) 1191-1200
26. Korovaitseva G.I., Bukina A., Farrer L.A., and Rogaev E.I. Presenilin polymorphisms in Alzheimer's disease. Lancet 350 (1997) 959
27. Kowalska A., Wender M., and Lannfelt L. Lack of association between an intronic polymorphism in the presenilin-1 gene and sporadic late-onset Alzheimer disease in Polish patients. Dement. Geriatr. Cogn Disord. 9 (1998) 137-139
28. Lehmann D.J., Williams J., McBroom J., and Smith A.D. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 108 (2001) 541-554
29. Lendon C.L., Myers A., Cumming A., Goate A.M., and St. Clair D. A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset. Neurosci. Lett. 228 (1997) 212-214
30. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.H., Guenette S.U., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., and Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
31. Liao A., Gomez-Isla T., Clatworthy A., and Hyman B.T. Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease. Brain Res. 816 (1999) 295-298
32. Mann D.M., Pickering-Brown S.M., Bayatti N.N., Wright A.E., Owen F., Iwatsubo T., and Saido T.C. An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's disease. Neurosci. Lett. 222 (1997) 57-60
33. Matsubara-Tsutsui M., Yamagata H., Morishima A., Nakura J., Mitsuda N., Kamino K., Kondo I., and Miki T. The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers. Intern. Med. 41 (2002) 823-828
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
35. Meshorer E., and Soreq H. Pre-mRNA splicing modulations in senescence. Aging Cell 1 (2002) 10-16
36. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van B.G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
37. Nishiwaki Y., Kamino K., Yoshiiwa A., Sato N., Tateishi K., Takeda M., Kobayashi T., Yamamoto H., Nonomura Y., Yoneda H., Sakai T., Imagawa M., Miki T., and Ogihara T. T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population. Neurosci. Lett. 227 (1997) 123-126
38. Papassotiropoulos A., Bagli M., Jessen F., Maier W., Forstl H., Kurz A., and Heun R. Interaction of two genes possibly involved in the regulation of the amyloid precursor protein (APP) processing. Mol. Psychiatry 5 (2000) 240-241
39. Perez-Tur J., Wavrant-De V.F., Lambert J.C., and Chartier-Harlin M.C. Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group. Lancet 347 (1996) 1560-1561
40. Rodriguez-Manotas M., Amorin-Diaz M., Vinals-Bellido I., Cabezas-Herrera J., Martinez-Hernandez P., and Canizares-Hernandez F. Real time PCR assay with fluorescent hybridization probes for genotyping intronic polymorphism in presenilin-1 gene. Clin. Chim. Acta 364 (2006) 343-344
41. Rodriguez-Martin T., Calella A.M., Silva S., Munna E., Modena P., Chiesa R., Terrevazzi S., Ruggieri R.M., Palermo R., Piccoli F., Confalonieri R., Tiraboschi P., Fragiacomo C., Quadri P., Lucca U., and Forloni G. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn Disord. 11 (2000) 239-244
42. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Lannfelt D., Fraser L., Rommens P.E., and St. George-Hyslop J.M. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
43. Romas S.N., Mayeux R., Tang M.X., Lantigua R., Medrano M., Tycko B., and Knowles J. No association between a presenilin 1 polymorphism and Alzheimer disease. Arch. Neurol. 57 (2000) 699-702
44. Scacchi R., Gambina G., Ruggeri M., Martini M.C., Ferrari G., Silvestri M., Schiavon R., and Corbo R.M. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci. Lett. 259 (1999) 33-36
45. Scott W.K., Yamaoka L.H., Locke P.A., Rosi B.L., Gaskell P.C., Saunders A.M., Conneally P.M., Small G.W., Farrer L.A., Growdon J.H., Roses A.D., Pericak-Vance M.A., and Haines J.L. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genet. Epidemiol. 14 (1997) 307-315
46. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sansequ P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., and St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
47. Singleton A.B., Lamb H., Leake A., McKeith I.G., Perry R.H., and Morris C.M. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neurosci. Lett. 234 (1997) 19-22
48. Sodeyama N., Itoh Y., Suematsu N., Matsushita M., Otomo E., Mizusawa H., and Yamada M. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 64 (1998) 548-551
49. Sorbi S., Nacmias B., Tedde A., Forleo P., Piacentini S., Latorraca S., and Amaducci L. Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. Neurosci. Lett. 222 (1997) 132-134
50. Taddei K., Yang D., Fisher C., Clarnette R., Hallmayer J., Barnetson R., Maller R., Brooks W.S., Whyte S., Nicholson G.A., Masters C.L., Broe G.A., Gandy S.E., and Martins R.N. No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia. Neurosci. Lett. 246 (1998) 178-180
51. Terwilliger J.D., and Ott J. Handbook of Human Genetic Linkage (1994), Johns Hopkins University Press, New York
52. Tilley L., Morgan K., Grainger J., Marsters P., Morgan L., Lowe J., Xuereb J., Wischik C., Harrington C., and Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur. J. Hum. Genet. 7 (1999) 659-663
53. Tysoe C., Whittaker J., Cairns N.J., Atkinson P.F., Harrington C.R., Xuereb J., Wilcock G., and Rubinsztein D.C. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci. Lett. 222 (1997) 68-69
54. van Duijn C.M., Cruts M., Theuns J., Van G.G., Backhovens H., Van den B.M., Wehnert A., Serneels S., Hofman A., and Van Broeckhoven C. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. Eur. J. Hum. Genet. 7 (1999) 801-806
55. Wang X., DeKosky S.T., Wisniewski S., and Kamboh M.I. Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease. Ann. Neurol. 44 (1998) 387-390
56. Williamson P.R., Gamble C., Altman D.G., and Hutton J.L. Outcome selection bias in meta-analysis. Stat. Methods Med. Res. 14 (2005) 515-524
57. Wragg M., Hutton M., and Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet 347 (1996) 509-512
58. Wu X., Jiang S., Lin S., Tang G., Feng G., Qian Y., Wang D., Ren D., and Gu N. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population. Am. J. Med. Genet. 88 (1999) 1-3
59. Yamada M., Sodeyama N., Itoh Y., Suematsu N., Otomo E., Matsushita M., and Mizusawa H. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 28 (1997) 2219-2221
60. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann. N. Y. Acad. Sci. 977 (2002) 37-44
61. Yasuda M., Hirono N., Maeda K., Imamura T., Mori E., and Tanaka C. Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 66 (1999) 722-726